Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)

被引:0
|
作者
Z. Wang
Z. Zhao
Y. Xia
Z. Cai
C. Wang
Y. Shen
R. Liu
H. Qin
J. Jia
G. Yuan
机构
[1] Affiliated Hospital of Jiangsu University,Department of Endocrinology
关键词
WGCNA; Single-cell RNA-seq; NASH; Fibrosis; HCC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:1379 / 1392
页数:13
相关论文
共 50 条
  • [21] VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Bzowej, Natalia
    Vuppalanchi, Raj
    Younes, Ziad
    Ding, Dora
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Wong, Vincent Wai-Sun
    Harrison, Stephen A.
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Goodman, Zackary
    HEPATOLOGY, 2019, 70 : 1342A - 1343A
  • [22] Phosphoproteomic Biomarkers Predicting Histologic Nonalcoholic Steatohepatitis and Fibrosis
    Younossi, Zobair M.
    Baranova, Ancha
    Stepanova, Maria
    Page, Sandra
    Calvert, Valerie S.
    Afendy, Arian
    Goodman, Zachary
    Chandhoke, Vikas
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2010, 9 (06) : 3218 - 3224
  • [23] Pathogenesis of nonalcoholic steatohepatitis (NASH)
    Pirlich, M
    Lochs, H
    Schmidt, HHJ
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (05): : 441 - 442
  • [24] Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis
    Harrison, Stephen A.
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    Caldwell, Stephen
    Shiffman, Mitchell L.
    Ghalib, Reem
    Lawitz, Eric
    Rockey, Don C.
    Schall, Raul E. Aguilar
    Jia, Catherine
    McColgan, Bryan J.
    Myers, Robert P.
    Subramanian, Mani
    McHutchison, John G.
    Muir, Andrew J.
    Ratziu, Vlad
    Afdhal, Nezam H.
    Goodman, Zachary D.
    Bosch, Jaime
    Sanyal, Arun J.
    HEPATOLOGY, 2017, 66 : 1120A - 1121A
  • [25] Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH)
    Sasaki, Nozomi
    Ueno, Takato
    Morita, Yasuyo
    Nagata, Eisuke
    Sata, Michio
    HEPATO-GASTROENTEROLOGY, 2006, 53 (71) : 678 - 681
  • [26] CLINICAL AND HISTOLOGICAL DETERMINANTS OF NONALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN THE ELDERLY
    Noureddin, Mazen
    Vaughn, Ivana A.
    Neuschwander-Tetri, Brent A.
    Sanyal, Arun J.
    McCullough, Arthur J.
    Merriman, Raphael B.
    Yates, Katherine P.
    Tonascia, James
    Unalp-Arida, Aynur
    Doo, Edward
    Kleiner, David E.
    Behling, Cynthia A.
    Loomba, Rohit
    HEPATOLOGY, 2011, 54 : 1118A - 1118A
  • [27] Clinical and biochemical predictors of advanced hepatic fibrosis in nonalcoholic steatohepatitis (NASH).
    Chitturi, S
    Fung, C
    Farrell, GC
    Samarasinghe, D
    Lin, R
    Liddle, C
    George, J
    HEPATOLOGY, 2000, 32 (04) : 535A - 535A
  • [28] Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    PROGRESS IN LIPID RESEARCH, 2023, 91
  • [29] Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice
    Rajak, Sangam
    Tewari, Archana
    Raza, Sana
    Gupta, Pratima
    Chakravarti, Bandana
    Anjum, Baby
    Tripathi, Madhulika
    Singh, Brijesh K.
    Yen, Paul M.
    Goel, Amit
    Ghosh, Sujoy
    Sinha, Rohit A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (04):
  • [30] Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis
    Joo, Jung Yeon
    Yoo, In Hyuk
    Yang, Hye Ran
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2024, 27 (04) : 236 - 245